Dexcom makes continuous glucose monitors diabetics wear to track blood sugar.
DexCom, Inc. (DXCM) is expected to report earnings on Thursday, October 29, 2026, after the close. Estimated release time 16:02 ET. Consensus EPS estimate is $0.67.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-07-30 | Jun 2026 qtr | $0.61 | $0.70 | +14.6% | $1.31B |
| 2026-04-30 | Mar 2026 qtr | $0.47 | $0.56 | — | $1.19B |
| 2026-02-12 | Dec 2025 qtr | $0.65 | $0.68 | +4.6% | $1.26B |
| 2025-10-30 | Sep 2025 qtr | $0.58 | $0.61 | +5.9% | $1.21B |
| 2025-07-30 | Jun 2025 qtr | $0.44 | $0.48 | +8.2% | $1.16B |
| 2025-05-01 | Mar 2025 qtr | $0.33 | $0.32 | -2.2% | $1.04B |
| 2025-02-13 | Dec 2024 qtr | $0.48 | $0.45 | -6.1% | $1.11B |
| 2024-10-24 | Sep 2024 qtr | $0.44 | $0.45 | +2.3% | $994.20M |
DXCM has beaten consensus EPS in 5 of its last 7 scored quarters.
See DXCM on the live calendar →